UPB
Upstream Bio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$6.01
−1.15%Margins
Gross margin
98.4%
EBITDA margin
-4950.9%
EBIT margin
-5382.6%
Net margin
-4955.7%
FCF margin
-4317.4%
-57.8%
Return on equity
-55.7%
Return on assets
-62.5%
Return on invested capital
0.01x
Asset turnover
-$136.3M
Cash from operations
$4.77
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026